Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 38.4919.51365.23-83.7020.61

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 38.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202538.49
Mar202419.51
Mar2023365.23
Mar2022-83.70
Mar202120.61

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2025 38.49
97.28
Mar2024 19.51
-94.66
Mar2023 365.23
Positive
Mar2022 -83.7
Negative
Mar2021 20.61 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹7,904.8 Cr -3% -4.8% 16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-3%

-4.8%

16.8%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses